Formulation Development and Optimization of Ceramic Nanoparticle for Delivery of Anticancer Drug

Kachkure, Nitin; Wadhave, Prof. Amol; Pundkar, Prof. Ashwini

doi:https://doi.org/10.55041/ijcope.v2i6.282

Volume 02, Issue 6

Published on: June 2026

FORMULATION DEVELOPMENT AND OPTIMIZATION OF CERAMIC NANOPARTICLE FOR DELIVERY OF ANTICANCER DRUG

Nitin Kachkure Prof. Amol Wadhave Prof. Ashwini Pundkar

Dr. Santosh Payghan

Dept. of Pharmaceutics, Rajesh Bhaiyya Tope College of Pharmacy, Chh.Sambhajinagar.

DOI:https://doi.org/10.55041/ijcope.v2i6.282

Article Status

Plagiarism Passed Peer Reviewed Open Access

Available Documents

Download PDF Review Report

Abstract

Nanoparticles in drug-delivery systems are generated by a variety of research survey. Unique physicochemical characteristics of nanostructured biomaterials include their very small and structural adaptability, high surface area to mass ratio, high reactivity, and controlled size. It enables molecularly focused cancer treatment, targeted administration of early detection of cancer lesions, early detection of cancer lesions, imaging agents, and anticancer medications, identification of tumor molecular factors by non-invasive imaging. These characteristics may be used in medicine to get around some of the drawbacks of conventional treatments. They are employed in vivo to protect the drug entity in the systemic circulation, limit drug access to the targeted areas, and deliver the drug to the site of action at a regulated and sustained pace. It reduces adverse side effects and enables more effective drug use. It must be active and therapeutically effective while in circulation and present at the target location in the right amounts. We will now go through several elements of nanoparticle formulation, the impact of their properties, characterization, and the potential of nanomedicine, improving targeted delivery of therapeutic agents, applications in drug molecule delivery, the development of novel, more powerful diagnostic and screening techniques to expand the boundaries of molecular diagnostics, and difficulties in synthesis nanoparticle platforms for dispensing various drugs.

Key Words: Ceramic nanoparticles, Dendrimers, Liposomes, Microbes, Polymeric nanoparticles, Solid lipid nano particles.

How to Cite this Paper

Kachkure, N., Wadhave, A. & Pundkar, A. (2026). Formulation Development and Optimization of Ceramic Nanoparticle for Delivery of Anticancer Drug. International Journal of Creative and Open Research in Engineering and Management, <i>02</i>(6). https://doi.org/10.55041/ijcope.v2i6.282

Kachkure, Nitin, et al.. "Formulation Development and Optimization of Ceramic Nanoparticle for Delivery of Anticancer Drug." International Journal of Creative and Open Research in Engineering and Management, vol. 02, no. 6, 2026, pp. . doi:https://doi.org/10.55041/ijcope.v2i6.282.

Kachkure, Nitin,Amol Wadhave, and Ashwini Pundkar. "Formulation Development and Optimization of Ceramic Nanoparticle for Delivery of Anticancer Drug." International Journal of Creative and Open Research in Engineering and Management 02, no. 6 (2026). https://doi.org/https://doi.org/10.55041/ijcope.v2i6.282.

Search & Index

References

Dole MN, Patel PA, Sawant SD, Shedpure PS., (2011) Advance applications of Fourier transform infrared spectroscopy. Int J Pharm Sci Rev Res.;7(2):159-166.

Kumar YA, Rao NR. (2010). Development of Rapid UV Spectrophotometric Method for the Estimation of Efavirenz in Formulations. E-Journal Chem. ;7(3):856-860.

Kadam AA, Babu CJG, Permal RV, Channabasavaraj K, Mani TT., (2012) Development and Validation of Method for the Quantitative Estimation of Efavirenz in Bulk and Pharmaceutical Dosage Form. Am J PharmTech Res.;2(1):324-330.

Seju U, Kumar A, Sawant KK. (2011). Development and evaluation of olanzapine-loaded PLGA nanoparticles for nose-to-brain delivery: In vitro and in vivo studies. Acta Biomater.;7(12):4169-4176.

Sharma D, Maheshwari D, Philip G, et al., (2014) Formulation and optimization of polymeric nanoparticles for intranasal delivery of Lorazepam using box-behnken design: in vitro and in vivo evaluation. Biomed Res Int.;2014:156010.

Government of India, Ministry of Health and Family Welfare. Indian Pharmacopoeia. The Indian Pharmacopoeia commission; 1996:A-147.

Ramachandran G, Kumar. KH, Swaminathan S, Venkatesan P, Kumaraswami V, Greenblatt DJ. (2006). Simple and rapid liquid chromatography method for determination of efavirenz in plasma. J Chromatogr B Anal Technol Biomed Life Sci. 2006;835(2):131-135.

Kamble RN, Mehta P., (2015). Development of simple HPLC method to estimate the blood plasma concentration of Efavirenz in rat after oral administration, Innovare Academic Sciences, Int. J Pharm & Pharm. Sci.;7(7):7-10.

Hughes GA. Nanostructure-mediated drug delivery. Nanomedicine 2005;1:22-30.

Zhang L, Gu FX, Chan JM, Wang AZ, Langer RS, Farokhzad OC. Nanoparticles in medicine: Therapeutic applications and developments. Clin Pharmacol Ther 2008; 83:761-9.

Ethical Compliance & Review Process

•All submissions are screened under plagiarism detection.
•Review follows editorial policy.
•Authors retain copyright.
•Peer Review Type: Double-Blind Peer Review
•Published on: Jun 22 2026

CCBYNC

This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. You are free to share and adapt this work for non-commercial purposes with proper attribution.

View License

Back to Volume 02, Issue 6 View All Issues Next Article

← Previous Article

Formulation and Physiochemical Evaluation of Transdermal Antiacene Patch Incorporating Bioactive Rich Psidium Guajava Leaf Extract

Next Article →

From Basavanna to Contemporary India: Equality, Justice, and Human Dignity in Girish Karnad's Taledanda